IF
InflaRx N.V.
IFRX · NASDAQ
$1.82 -3.19% (-$0.06)
1M -14.55%
Market Cap 235.7M €
P/E Ratio -
Div. Yield -
ROE 58.00%
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
99 /100
Cheap P/S -23,333.30x
P/B 1.61x
P/E N/A
Growth
0 /100
Declining Book val. growth 22.24%
EPS growth N/A
Rev. growth N/A
Profitability
100 /100
Strong Gross margin 48,201.60%
Net margin 387,532.00%
Op. margin 362,271.00%
Quality
0 /100
Poor ROIC 24.90%
ROE 58.00%
ROA 23.46%
Debt
69 /100
Low Debt/Equity 0.01x
Current ratio 8.22x
Int. coverage -651.79x
Stability
37 /100
Moderate Beta 2.54x
EPS volatility 21.92%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IFRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Niels C. Riedemann
Employees
65
Headquarters
Jena
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report